PURE BIOSCIENCE Reports Q2 2026 Financial Results

What Happened
PURE BIOSCIENCE, Inc. announced its financial results for the fiscal second quarter ended January 31, 2026 via a press release dated March 16, 2026 and furnished to the SEC in an 8-K filed March 17, 2026. The 8-K (Item 2.02) discloses the company issued a press release with the quarterly results; the press release is attached as Exhibit 99.1 to the filing.

Key Details

• Filing: Form 8-K filed March 17, 2026 reporting results of operations (Item 2.02).
• Quarter: Fiscal Q2 ended January 31, 2026; press release dated March 16, 2026 (Exhibit 99.1).
• Exhibit status: Exhibit 99.1 is furnished (not “filed”) and therefore not subject to Section 18 liability or incorporated by reference into registration statements.
• Technical: The filing includes the Inline XBRL cover page interactive data file.

Why It Matters
This filing notifies investors that PURE has released its latest quarterly earnings and related financial information — key data that investors use to assess revenue, profitability, cash position and near-term outlook. Because the 8-K furnishes (but does not file) the press release, investors should read the attached Exhibit 99.1 for the specific figures (revenue, net income/loss, guidance, cash) and watch for any follow-up SEC filings (e.g., quarterly report on Form 10-Q) for audited or expanded disclosures.